Nutraplus India Limited says business closure vitiates going concern
Key highlights
- Nutraplus reported Rs 0 revenue from operations in the quarter ended September 30, 2026.
- Nutraplus said all property, plant and equipment were lost through a bank auction process.
- Nutraplus reported negative total equity of Rs 4.91 crore at September 30, 2026.
- Nutraplus reported Rs 8.54 crore of trade payables to creditors other than micro and small enterprises.
powered by IRIS

Nutraplus India Limited said its going-concern concept was “completely vitiated” at September 30, 2026, after the loss of all property, plant and equipment and closure of business activities, while reporting zero operating revenue and negative total equity of Rs 4.91 crore. The company also said there was no hope of a restructuring plan.
Know Nutraplus India inside out
Results, valuation, peers and who's buying, in one view.
Why does Nutraplus say its going-concern concept is vitiated?
Nutraplus said its going-concern concept was “completely vitiated” because it lost all property, plant and equipment under the Act cited in the filing as the SARFESIA Act, 2002. The company said it was declared a non-performing asset in financial year 2019-20 and that the bank auction of its assets, delayed during the COVID-19 epidemic, was ultimately completed.
The company stated that all business activities had closed and that it had lost key employees in finance, accounts, legal, production and marketing. It also said there was “no hope” for a restructuring plan. Its balance sheet at September 30, 2026 recorded nil property, plant and equipment, nil capital work-in-progress and nil intangible assets.
Nutraplus said the accounts were prepared on available information after the loss of key personnel and that all ledger accounts were without confirmation. The board approved the unaudited standalone results on November 14, 2026 after review and recommendation by the audit committee, while the statutory auditors carried out a limited review under the applicable listing rules.
Did Nutraplus generate any operating revenue in September 2026?
Nutraplus generated Rs 0 revenue from operations in the quarter ended September 30, 2026, matching the June 30, 2026 quarter and the quarter ended September 30, 2025. The company identifies active pharmaceutical ingredient, or API, as its single operating segment, so the reported zero revenue covers its disclosed business segment.
Total income was also Rs 0 in the September 2026 quarter, compared with Rs 3.19 lakh in the June 2026 quarter and Rs 9.67 lakh in the September 2025 quarter. The prior-period income consisted of other income, as revenue from operations was Rs 0 in each of the three quarters.
Expenses fell to Rs 1.47 lakh in the September 2026 quarter from Rs 45.53 lakh a year earlier. Other expenses declined to Rs 1.09 lakh from Rs 45.14 lakh, while employee-benefit expense was unchanged at Rs 0.36 lakh. Finance cost was Rs 0.02 lakh, compared with Rs 0 in the September 2025 quarter.
Nutraplus reported a net loss after tax of Rs 1.47 lakh for the September 2026 quarter, compared with a loss of Rs 35.86 lakh in the corresponding quarter a year earlier. The reduction in the reported loss coincided with lower expenses, not a recovery in sales, because operating revenue remained Rs 0. For the period ended September 30, 2026, the company reported profit after tax of Rs 0.20 lakh against a Rs 36.51 lakh loss in the corresponding prior-year period.
What do Nutraplus’s assets, liabilities and equity show?
Nutraplus reported total assets of Rs 5.00 crore at September 30, 2026, unchanged from March 31, 2026, and total equity of negative Rs 4.91 crore, compared with negative Rs 5.69 crore at the previous year-end. Current assets accounted for Rs 5.00 crore, while non-current assets consisted solely of investments of Rs 0.02 lakh.
Other current assets were the largest disclosed asset line at Rs 3.89 crore. Loans were Rs 51.24 lakh, trade receivables were Rs 33.54 lakh, investments were Rs 15 lakh, and cash and cash equivalents were Rs 1.48 lakh. Bank balances other than cash equivalents were Rs 4.70 lakh. Each of those current-asset balances was unchanged from March 31, 2026.
Trade payables due to creditors other than micro and small enterprises rose by Rs 6.50 lakh over the six months to Rs 8.54 crore. Non-current borrowings fell by Rs 2.94 lakh to Rs 2.14 crore. The balance sheet showed no current borrowings, no lease liabilities and no dues to micro and small enterprises at September 30, 2026.
Got a follow-up? Ask IRIS
Do Nutraplus’s reported balance-sheet totals reconcile?
No, the September 30, 2026 balance sheet does not reconcile on its face because it reports total assets of Rs 5.00 crore and total equity and liabilities of Rs 5.77 crore. The difference between the two displayed totals is Rs 77.64 lakh, and the accompanying notes provide no explanation for that presentation.
The reported movement in other equity is separately Rs 77.84 lakh: other equity was negative Rs 21.96 crore at September 30, 2026, compared with negative Rs 22.74 crore at March 31, 2026. However, the statement of results reports profit after tax of only Rs 0.20 lakh for the period ended September 30, 2026, and does not identify any item explaining the other-equity movement.
This comparison is based only on the figures presented in the filing and does not establish the cause of the difference. Nutraplus disclosed that its ledgers were unconfirmed and that accounts were prepared using available information after key employees left following the closure of business activities. The filing does not say whether the company intends to revise, restate or explain the balance-sheet totals.
What does Nutraplus’s cash-flow statement disclose?
Nutraplus’s cash-flow statement reported cash and cash equivalents of Rs 6.18 lakh at the end of the stated period, unchanged from Rs 6.18 lakh at the beginning. This total corresponds to the Rs 1.48 lakh cash-and-cash-equivalents balance and Rs 4.70 lakh of other bank balances shown on the September 30, 2026 balance sheet.
Net cash generated from operating activities was Rs 2.94 lakh, offset by Rs 2.94 lakh of net cash used in financing activities, resulting in no net change in cash. The operating movement included a Rs 2.74 lakh increase in other current liabilities. The financing section shows proceeds from borrowings of negative Rs 2.94 lakh, consistent with the decline in non-current borrowings from Rs 2.17 crore at March 31, 2026 to Rs 2.14 crore at September 30, 2026.
The cash-flow statement labels the September 30, 2026 column as “Year Ended” and “Audited.” That differs from the November 14, 2026 board announcement and results statement, which describe the released financial results as unaudited standalone results for the quarter and half year ended September 30, 2026.
Conclusion
Nutraplus has disclosed the cessation of its API business activities, rather than operating revenue from that segment. The company reported Rs 0 operating revenue in the September 2026 quarter, nil recorded property, plant and equipment, negative equity of Rs 4.91 crore and total liabilities of Rs 10.68 crore, while management said the going-concern concept had been completely vitiated.
The next disclosed matters to watch are whether Nutraplus explains the Rs 77.64 lakh gap between its displayed asset total and total equity-and-liabilities figure, and whether a later filing changes its stated position that no restructuring plan is expected. Any clarification of unconfirmed ledger balances or the differing cash-flow period label would also address matters identified in the November 14, 2026 filing.


